Effect of fixed-ratio insulin combinations on adherence in type 2 diabetes: Systematic review

被引:1
作者
Elamin, Mohamed [1 ]
Barnish, Maxwell S. [2 ]
机构
[1] Univ Exeter, Med Sch, Exeter, England
[2] Univ Exeter, Med Sch, Dept Publ Hlth & Sports Sci, Exeter, England
关键词
Type; 2; diabetes; Fixed -ratio combinations; Adherence; Narrative synthesis; BASAL INSULIN; REAL-WORLD; IDEGLIRA; BARRIERS; THERAPY; PEOPLE; SAFETY;
D O I
10.1016/j.dsx.2024.103072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To systematically review evidence on the effect of fixed-ratio combinations on adherence in people with type 2 diabetes. Methods: Systematic searches were conducted using MEDLINE and EMBASE in March 2023. Standardised screening, data extraction and risk of bias assessment were conducted. All review procedures were conducted independently by two reviewers. Eligible studies assessed the effect of fixed-ratio combinations on adherence in people with type 2 diabetes. Narrative synthesis was conducted to analyse findings. Results: A total of 488 records were identified, of which 37 proceeded to full-text screening and 7 - each representing a unique study - were included in the systematic review. Among the included studies, 3 were randomised controlled trials and 4 were cohort studies. Following narrative synthesis, it was shown that fixed-ratio combinations improved patient satisfaction and treatment adherence. Conclusions: Available evidence supports a benefit for fixed-ratio combinations on patient satisfaction and treatment adherence in people with type 2 diabetes.
引用
收藏
页数:7
相关论文
共 37 条
[11]  
Diabetes UK, 2019, facts-stats-update-oct-2019
[12]   Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes [J].
Donnelly, L. A. ;
Morris, A. D. ;
Evans, J. M. M. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (06) :345-350
[13]   Physicians' real-world experience with IDegLira: results of a European survey [J].
Drummond, Russell ;
Baru, Ankita ;
Dutkiewicz, Marcelina ;
Basse, Amaury ;
Tengmark, Bengt-Olov .
BMJ OPEN DIABETES RESEARCH & CARE, 2018, 6 (01)
[14]  
Edelman S, 2022, J MANAG CARE SPEC PH, V28, P958, DOI 10.18553/jmcp.2022.28.9.958
[15]   Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis [J].
Edina, Brenda C. ;
Tandaju, Jeremy R. ;
Wiyono, Lowilius .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
[16]   Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis [J].
Ellis, Kathy ;
Mulnier, Henrietta ;
Forbes, Angus .
BMC FAMILY PRACTICE, 2018, 19
[17]  
Gherman A., 2011, Practical Diabetes International, V28, P125, DOI [DOI 10.1002/PDI.1574, 10.1002/pdi.1574]
[18]   Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes [J].
Guerci, Bruno ;
Chanan, Neha ;
Kaur, Simarjeet ;
Jasso-Mosqueda, Juan Guillermo ;
Lew, Elisheva .
DIABETES THERAPY, 2019, 10 (02) :437-449
[19]   Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update [J].
Hanefeld, Markolf ;
Fleischmann, Holger ;
Siegmund, Thorsten ;
Seufert, Jochen .
DIABETES THERAPY, 2020, 11 (08) :1645-1666
[20]   Expert Panel Guidance and Narrative Review of Treatment Simplification of Complex Insulin Regimens to Improve Outcomes in Type 2 Diabetes [J].
Jude, Edward B. ;
Malecki, Maciej T. ;
Gomez Huelgas, Ricardo ;
Prazny, Martin ;
Snoek, Frank ;
Tankova, Tsvetalina ;
Giugliano, Dario ;
Khunti, Kamlesh .
DIABETES THERAPY, 2022, 13 (04) :619-634